JA Solar Announces First Quarter 2017 Results
May 24, 2017 11:10 am UTC| Business
BEIJING, May 24, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced its unaudited...
JA Solar Announces First Quarter 2017 Results
May 24, 2017 11:10 am UTC| Business
BEIJING, May 24, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced its unaudited...
JA Solar Announces First Quarter 2017 Results
May 24, 2017 11:10 am UTC| Business
BEIJING, May 24, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced its unaudited...
JA Solar Announces First Quarter 2017 Results
May 24, 2017 11:10 am UTC| Business
BEIJING, May 24, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced its unaudited...
JA Solar Announces First Quarter 2017 Results
May 24, 2017 11:10 am UTC| Business
BEIJING, May 24, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced its unaudited...
May 24, 2017 11:09 am UTC| Business
BOULDER, Colo., May 24, 2017 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the European...
May 24, 2017 11:09 am UTC| Business
BOULDER, Colo., May 24, 2017 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that the European...